Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 60.7017.583.14-40.091,061.31

What is the latest EBIT Growth ratio of VENUS REMEDIES ?

The latest EBIT Growth ratio of VENUS REMEDIES is 60.70 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202560.70
Mar202417.58
Mar20233.14
Mar2022-40.09
Mar20211,061.31

How is EBIT Growth of VENUS REMEDIES Trending?

Years EBIT Growth % Change
Mar2025 60.7
245.28
Mar2024 17.58
459.87
Mar2023 3.14
Positive
Mar2022 -40.09
Negative
Mar2021 1061.31 -

Other Financial Ratios of VENUS REMEDIES


Compare EBIT Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹662.8 Cr 0.7% -10.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,419.0 Cr -0.3% -3.4% -6.9% Stock Analytics
DIVIS LABORATORIES ₹159,986.0 Cr -1.6% -10.2% 30.3% Stock Analytics
CIPLA ₹128,659.0 Cr -1% 4.8% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,448.0 Cr 1.2% 3.9% 9% Stock Analytics
DR REDDYS LABORATORIES ₹106,539.0 Cr -0.6% -1.1% -9.9% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

0.7%

-10.2%

40%

SENSEX

1.8%

-0.2%

2%


You may also like the below Video Courses